Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five analysts that are presently covering the firm, Ratings reports.
Some results have been hidden because they may be inaccessible to you